{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:02:21Z","timestamp":1790949741196,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI165466"],"award-info":[{"award-number":["R01AI165466"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI127375"],"award-info":[{"award-number":["R01AI127375"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI162789"],"award-info":[{"award-number":["R01AI162789"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007631","name":"Canadian Institute for Advanced Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007631","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020940","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI127375"],"award-info":[{"award-number":["R01AI127375"]}],"id":[{"id":"10.13039\/100020940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020940","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI165466"],"award-info":[{"award-number":["R01AI165466"]}],"id":[{"id":"10.13039\/100020940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-154288"],"award-info":[{"award-number":["FDN-154288"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bmn.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.molmed.2024.04.018","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:10:27Z","timestamp":1716250227000},"page":"723-735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Interdisciplinary approaches for the discovery of novel antifungals"],"prefix":"10.1016","volume":"30","author":[{"given":"Bonnie","family":"Yiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5797-0110","authenticated-orcid":false,"given":"Leah E.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2024.04.018_bb0005","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.molmed.2024.04.018_bb0010","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00449-20","article-title":"Threats posed by the fungal kingdom to humans, wildlife, and agriculture","volume":"11","author":"Fisher","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.molmed.2024.04.018_bb0015","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00142-23","article-title":"Advancements and challenges in antifungal therapeutic development","author":"Puumala","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.molmed.2024.04.018_bb0020","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41579-021-00511-0","article-title":"Treatment strategies for cryptococcal infection: challenges, advances and future outlook","volume":"19","author":"Iyer","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0025","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1021\/acs.chemrev.0c00199","article-title":"Antifungal drug resistance: molecular mechanisms in Candida albicans and beyond","volume":"121","author":"Lee","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.molmed.2024.04.018_bb0030","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.FUNK-0002-2016","article-title":"Antifungal drugs: the current armamentarium and development of new agents","volume":"4","author":"Robbins","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.molmed.2024.04.018_bb0035","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd.2017.46","article-title":"The antifungal pipeline: a reality check","volume":"16","author":"Perfect","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2024.04.018_bb0040","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nchembio.1496","article-title":"Amphotericin forms an extramembranous and fungicidal sterol sponge","volume":"10","author":"Anderson","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0045","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.molmed.2024.04.018_bb0050","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/mmy\/myz083","article-title":"Ibrexafungerp: a novel oral glucan synthase inhibitor","volume":"58","author":"Davis","year":"2019","journal-title":"Med. Mycol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0055","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1016\/j.bmcl.2014.05.068","article-title":"Design and optimization of highly-selective fungal CYP51 inhibitors","volume":"24","author":"Hoekstra","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.molmed.2024.04.018_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2022.07.023","article-title":"Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections","volume":"227","author":"Martens","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0065","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s40265-022-01734-y","article-title":"Oteseconazole: first approval","volume":"82","author":"Hoy","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.molmed.2024.04.018_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1321517","article-title":"Enhancement of antifungal activity and transdermal delivery of 5-flucytosine via tailored spanlastic nanovesicles: statistical optimization, in-vitro characterization, and in-vivo biodistribution study","volume":"14","author":"Safhi","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/MMBR.00045-10","article-title":"Regulatory circuitry governing fungal development, drug resistance, and disease","volume":"75","author":"Shapiro","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.molmed.2024.04.018_bb0080","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/s41586-023-06710-4","article-title":"Tuning sterol extraction kinetics yields a renal-sparing polyene antifungal","volume":"623","author":"Maji","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.04.018_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001692","article-title":"Fitness trade-offs restrict the evolution of resistance to amphotericin B","volume":"11","author":"Vincent","year":"2013","journal-title":"PLoS Biol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/21505594.2016.1196300","article-title":"Combinatorial strategies for combating invasive fungal infections","volume":"8","author":"Spitzer","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.molmed.2024.04.018_bb0095","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America","volume":"30","author":"Saag","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molmed.2024.04.018_bb0100","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1038\/s41467-020-20183-3","article-title":"An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris","volume":"11","author":"Iyer","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.04.018_bb0105","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature16963","article-title":"Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction","volume":"530","author":"Nishikawa","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.04.018_bb0110","doi-asserted-by":"crossref","first-page":"11893","DOI":"10.1021\/acs.jmedchem.3c00488","article-title":"Discovery of pyrazolone carbothioamide derivatives as inhibitors of the Pdr1-KIX interaction for combinational treatment of azole-resistant candidiasis","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molmed.2024.04.018_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103953","article-title":"The role of Candida albicans stress response pathways in antifungal tolerance and resistance","volume":"25","author":"Iyer","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.molmed.2024.04.018_bb0120","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.tim.2017.05.003","article-title":"The Hsp90 chaperone network modulates candida virulence traits","volume":"25","author":"O'Meara","year":"2017","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.mib.2013.03.005","article-title":"The fungal Achilles' heel: targeting Hsp90 to cripple fungal pathogens","volume":"16","author":"Cowen","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2023.102351","article-title":"Roles of Hsp90 in Candida albicans morphogenesis and virulence","volume":"75","author":"Robbins","year":"2023","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0135","doi-asserted-by":"crossref","DOI":"10.1093\/genetics\/iyab164","article-title":"Genetic analysis of Hsp90 function in Cryptococcus neoformans highlights key roles in stress tolerance and virulence","volume":"220","author":"Fu","year":"2022","journal-title":"Genetics"},{"key":"10.1016\/j.molmed.2024.04.018_bb0140","article-title":"Genetic analysis of Candida auris implicates Hsp90 in morphogenesis and azole tolerance and cdr1 in azole resistance","volume":"10","author":"Kim","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.molmed.2024.04.018_bb0145","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1073\/pnas.0813394106","article-title":"Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease","volume":"106","author":"Cowen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molmed.2024.04.018_bb0150","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1126\/science.1118370","article-title":"Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi","volume":"309","author":"Cowen","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.molmed.2024.04.018_bb0155","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1128\/EC.00032-12","article-title":"Heat shock protein 90 is required for conidiation and cell wall integrity in Aspergillus fumigatus","volume":"11","author":"Lamoth","year":"2012","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.molmed.2024.04.018_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000532","article-title":"Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin","volume":"5","author":"Singh","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2024.04.018_bb0165","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.celrep.2018.04.084","article-title":"Functional genomic screening reveals core modulators of echinocandin stress responses in Candida albicans","volume":"23","author":"Caplan","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2024.04.018_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001069","article-title":"PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90","volume":"6","author":"LaFayette","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2024.04.018_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002257","article-title":"Hsp90 governs dispersion and drug resistance of fungal biofilms","volume":"7","author":"Robbins","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2024.04.018_bb0180","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cub.2009.03.017","article-title":"Hsp90 orchestrates temperature-dependent Candida albicans morphogenesis via Ras1-PKA signaling","volume":"19","author":"Shapiro","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.molcel.2006.12.008","article-title":"An acetylation site in the middle domain of Hsp90 regulates chaperone function","volume":"25","author":"Scroggins","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2024.04.018_bb0190","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.celrep.2012.08.035","article-title":"Lysine deacetylases Hda1 and Rpd3 regulate Hsp90 function thereby governing fungal drug resistance","volume":"2","author":"Robbins","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2024.04.018_bb0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev.biochem.76.052705.162114","article-title":"Functions of site-specific histone acetylation and deacetylation","volume":"76","author":"Shahbazian","year":"2007","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/j.molmed.2024.04.018_bb0200","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrm2346","article-title":"The Rpd3\/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men","volume":"9","author":"Yang","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0205","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1128\/JCM.00618-09","article-title":"Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens","volume":"47","author":"Pfaller","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.diagmicrobio.2014.11.008","article-title":"In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species","volume":"81","author":"Pfaller","year":"2015","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.molmed.2024.04.018_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113961","article-title":"Heat shock protein 90 (Hsp90)\/Histone deacetylase (HDAC) dual inhibitors for the treatment of azoles-resistant Candida albicans","volume":"227","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.molmed.2024.04.018_bb0220","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/s41564-024-01662-5","article-title":"A dual-targeting antifungal is effective against multidrug-resistant human fungal pathogens","volume":"9","author":"Zhou","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0225","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41586-023-05856-5","article-title":"Structural and mechanistic insights into fungal beta-1,3-glucan synthase FKS1","volume":"616","author":"Hu","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.04.018_bb0230","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1021\/acs.jmedchem.0c01777","article-title":"Fungal-selective resorcylate aminopyrazole Hsp90 inhibitors: optimization of whole-cell anticryptococcal activity and insights into the structural origins of cryptococcal selectivity","volume":"64","author":"Marcyk","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molmed.2024.04.018_bb0235","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/acs.jmedchem.9b00826","article-title":"Design and synthesis of fungal-selective resorcylate aminopyrazole Hsp90 inhibitors","volume":"63","author":"Huang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molmed.2024.04.018_bb0240","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41467-018-08248-w","article-title":"Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus","volume":"10","author":"Whitesell","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.04.018_bb0245","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1021\/acs.jmedchem.1c01991","article-title":"Species-selective targeting of fungal hsp90: design, synthesis, and evaluation of novel 4,5-diarylisoxazole derivatives for the combination treatment of azole-resistant candidiasis","volume":"65","author":"Yin","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molmed.2024.04.018_bb0250","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1038\/s41467-019-12199-1","article-title":"Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents","volume":"10","author":"Juvvadi","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.04.018_bb0255","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.chembiol.2019.12.008","article-title":"Overcoming fungal echinocandin resistance through inhibition of the non-essential stress kinase Yck2","volume":"27","author":"Caplan","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0260","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1021\/id5000212","article-title":"Chemical genomics-based antifungal drug discovery: targeting glycosylphosphatidylinositol (GPI) precursor biosynthesis","volume":"1","author":"Mann","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.molmed.2024.04.018_bb0265","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1021\/cb300235m","article-title":"Inhibiting GPI anchor biosynthesis in fungi stresses the endoplasmic reticulum and enhances immunogenicity","volume":"7","author":"McLellan","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0270","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.chembiol.2023.06.005","article-title":"Identification of triazenyl indoles as inhibitors of fungal fatty acid biosynthesis with broad-spectrum activity","volume":"30","author":"Iyer","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0275","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.abd6919","article-title":"A marine microbiome antifungal targets urgent-threat drug-resistant fungi","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.molmed.2024.04.018_bb0280","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2958.2003.03697.x","article-title":"Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery","volume":"50","author":"Roemer","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0285","first-page":"6741","article-title":"Leveraging machine learning essentiality predictions and chemogenomic interactions to identify novel antifungal targets","volume":"6","author":"Fu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.04.018_bb0290","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1038\/ncomms7741","article-title":"Global analysis of fungal morphology exposes mechanisms of host cell escape","volume":"6","author":"O'Meara","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.04.018_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104432","article-title":"Functional analysis of the Candida albicans kinome reveals Hrr25 as a regulator of antifungal susceptibility","volume":"25","author":"Lee","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.molmed.2024.04.018_bb0300","article-title":"Functional analysis of the Aspergillus fumigatus kinome reveals a DYRK kinase involved in septal plugging is a novel antifungal drug target","author":"van Rhijn","year":"2023","journal-title":"Res. Sq."},{"key":"10.1016\/j.molmed.2024.04.018_bb0305","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.cell.2014.10.044","article-title":"Unraveling the biology of a fungal meningitis pathogen using chemical genetics","volume":"159","author":"Brown","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2024.04.018_bb0310","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/s41467-020-15329-2","article-title":"Fungal kinases and transcription factors regulating brain infection in Cryptococcus neoformans","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.04.018_bb0315","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nchembio.2007.24","article-title":"Targeting virulence: a new paradigm for antimicrobial therapy","volume":"3","author":"Clatworthy","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0320","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drudis.2008.11.013","article-title":"Targeting virulence: a new paradigm for antifungals","volume":"14","author":"Gauwerky","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.molmed.2024.04.018_bb0325","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrmicro.2016.157","article-title":"Candida albicans cell-type switching and functional plasticity in the mammalian host","volume":"15","author":"Noble","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0330","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/ng.605","article-title":"Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity","volume":"42","author":"Noble","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2024.04.018_bb0335","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.1305982110","article-title":"Chemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis","volume":"110","author":"Fazly","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molmed.2024.04.018_bb0340","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02183-23","article-title":"DYRK-family kinases regulate Candida albicans morphogenesis and virulence through the Ras1\/PKA pathway","volume":"14","author":"MacAlpine","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.molmed.2024.04.018_bb0345","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1038\/s41467-021-26390-w","article-title":"A small molecule produced by Lactobacillus species blocks Candida albicans filamentation by inhibiting a DYRK1-family kinase","volume":"12","author":"MacAlpine","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.04.018_bb0350","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75490","article-title":"The Candida albicans virulence factor candidalysin polymerizes in solution to form membrane pores and damage epithelial cells","volume":"11","author":"Russell","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.molmed.2024.04.018_bb0355","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/imm.13255","article-title":"Candida albicans and candidalysin in inflammatory disorders and cancer","volume":"162","author":"Ho","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.molmed.2024.04.018_bb0360","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/j.immuni.2021.08.009","article-title":"Candida albicans elicits protective allergic responses via platelet mediated T helper 2 and T helper 17 cell polarization","volume":"54","author":"Wu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.molmed.2024.04.018_bb0365","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/toxins12080469","article-title":"The dual function of the fungal toxin candidalysin during candida albicans-macrophage interaction and virulence","volume":"12","author":"Konig","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.molmed.2024.04.018_bb0370","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03409-23","article-title":"Nanobody-mediated neutralization of candidalysin prevents epithelial damage and inflammatory responses that drive vulvovaginal candidiasis pathogenesis","volume":"15","author":"Valentine","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.molmed.2024.04.018_bb0375","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.chembiol.2016.06.016","article-title":"A fungal-selective cytochrome bc1 inhibitor impairs virulence and prevents the evolution of drug resistance","volume":"23","author":"Vincent","year":"2016","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0380","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1038\/s41467-023-40209-w","article-title":"Multifactor transcriptional control of alternative oxidase induction integrates diverse environmental inputs to enable fungal virulence","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.04.018_bb0385","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.str.2021.08.006","article-title":"Rieske head domain dynamics and indazole-derivative inhibition of Candida albicans complex III","volume":"30","author":"Di Trani","year":"2022","journal-title":"Structure"},{"key":"10.1016\/j.molmed.2024.04.018_bb0390","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1038\/ncomms5029","article-title":"Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action","volume":"5","author":"Birth","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2024.04.018_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095951","article-title":"Inhibitors of the glyoxylate cycle enzyme ICL1 in Candida albicans for potential use as antifungal agents","volume":"9","author":"Cheah","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2024.04.018_bb0400","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2024.04.018_bb0405","article-title":"Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19","volume":"118","author":"Mirabelli","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.molmed.2024.04.018_bb0410","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S1473-3099(16)00074-8","article-title":"Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study","volume":"16","author":"Rhein","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.molmed.2024.04.018_bb0415","doi-asserted-by":"crossref","first-page":"8","DOI":"10.12688\/wellcomeopenres.15010.1","article-title":"A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis","volume":"4","author":"Ngan","year":"2019","journal-title":"Wellcome Open Res."},{"key":"10.1016\/j.molmed.2024.04.018_bb0420","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/jof5040092","article-title":"Repositionable compounds with antifungal activity against multidrug resistant Candida auris identified in the medicines for malaria venture's pathogen box","volume":"5","author":"Wall","year":"2019","journal-title":"J. Fungi (Basel)"},{"key":"10.1016\/j.molmed.2024.04.018_bb0425","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00537-17","article-title":"Novel antifungal compounds discovered in medicines for malaria venture's malaria box","volume":"3","author":"Jung","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.molmed.2024.04.018_bb0430","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00120-17","article-title":"Discovery of a novel antifungal agent in the pathogen box","volume":"2","author":"Mayer","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.molmed.2024.04.018_bb0435","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41589-023-01349-8","article-title":"Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii","volume":"19","author":"Liu","year":"2023","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0440","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41564-023-01542-4","article-title":"Aspergillus fumigatus strains that evolve resistance to the agrochemical fungicide ipflufenoquin in vitro are also resistant to olorofim","volume":"9","author":"van Rhijn","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.molmed.2024.04.018_bb0445","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.14484","article-title":"Advances in fungal chemical genomics for the discovery of new antifungal agents","volume":"1496","author":"Xue","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.molmed.2024.04.018_bb0450","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/6791","article-title":"Genomic profiling of drug sensitivities via induced haploinsufficiency","volume":"21","author":"Giaever","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2024.04.018_bb0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030092","article-title":"Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans","volume":"3","author":"Xu","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.molmed.2024.04.018_bb0460","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1073\/pnas.0307490100","article-title":"Chemogenomic profiling: identifying the functional interactions of small molecules in yeast","volume":"101","author":"Giaever","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424001217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491424001217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T11:12:48Z","timestamp":1723633968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491424001217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":92,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1471491424001217"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2024.04.018","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interdisciplinary approaches for the discovery of novel antifungals","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2024.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}